Michelle Fransen Shares A Historical Review on Plasma-Derived Medicinal Products
Michelle Fransen, Director, Lead for Study Management at Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”I am thrilled to share that Dr. Toby Simon and I had our article, “Source plasma apheresis and plasma-derived medicinal products: a historical review” published in the most recent issue Annals of Blood.
This paper, which can be found here, outlines the history of plasmapheresis and PDMP manufacturing which spans more than a century of scientific and clinical innovation.
We believe that understanding this history is more than academic—it underscores how continued innovation, strong regulatory oversight, and a focus on donor health are essential to sustaining a global plasma supply and advancing care for patients with immune deficiencies, coagulation disorders, and other rare diseases.”
Read the full article here.
Article: Source plasma apheresis and plasma-derived medicinal products: a historical review
Authors: Michelle Fransen, Toby Simon
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 27, 2026, 06:45Maha Othman: The Value of Trusted Scientific Reporting at ISTH 2026
-
Jul 27, 2026, 04:50A Significant Step Forward for People with Bleeding Disorders in the Dominican Republic – WFH
-
Jul 27, 2026, 04:11Mohamed F Doheim: Clarifying the Role of Late IV Thrombolysis in the Era of Endovascular Therapy
-
Jul 27, 2026, 03:50Françoise Dignat-George: The Rising Impact of Extracellular Vesicles Spotlighted at ISTH 2026
-
Jul 27, 2026, 03:42Koson Tony Sriamporn: A Milestone for Inclusive Blood Donor Eligibility
-
Jul 27, 2026, 03:34Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026
-
Jul 26, 2026, 23:18Mohammadmahdi Sabahi: Proud to Share Our Complete Cushing’s Disease Research Collection
-
Jul 26, 2026, 22:59Mahmood Naseri: The Results of the 2nd Clinical Trial on AriClot Are Now Live in Burns Journal
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart